Bortezomib delays the onset of factor VIII inhibitors in experimental hemophilia A, but fails to eliminate established anti-factor VIII IgG-producing cells

Y. Meslier; S. Andre; J. Dimitrov; S. Delignat; Jagadeesh Bayry; S. Kaveri; S. Lacroix-Desmazes

doi:10.1111/j.1538-7836.2011.04200.x

Journal articles

Bortezomib delays the onset of factor VIII inhibitors in experimental hemophilia A, but fails to eliminate established anti-factor VIII IgG-producing cells

Y. Meslier S. Andre J. Dimitrov S. Delignat ¹ Jagadeesh Bayry ^{2, 3, 4, 5} S. Kaveri ⁶ S. Lacroix-Desmazes ²

1 Immunopathologie et immunointervention thérapeutique

2 CRC - Centre de Recherche des Cordeliers

3 UPMC - Université Pierre et Marie Curie - Paris 6 - UFR de Médecine Pierre et Marie Curie

4 USPC - Université Sorbonne Paris Cité

5 INSERM - Institut National de la Santé et de la Recherche Médicale

6 INSERM, U872, Equipe 7, Paris, France

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Immunology / Innate immunity

Life Sciences [q-bio] / Immunology / Allergology

Complete list of metadata

https://www.hal.inserm.fr/inserm-02455569
Contributor : Jagadeesh Bayry Connect in order to contact the contributor
Submitted on : Sunday, January 26, 2020 - 11:49:44 AM
Last modification on : Thursday, November 18, 2021 - 4:09:24 AM

Bortezomib delays the onset of factor VIII inhibitors in experimental hemophilia A, but fails to eliminate established anti-factor VIII IgG-producing cells

Identifiers

Collections

Citation

Export

Metrics

24

Bortezomib delays the onset of factor VIII inhibitors in experimental hemophilia A, but fails to eliminate established anti-factor VIII IgG-producing cells

Identifiers

Collections

Citation

Export

Share

Metrics

24